
New IVIG stored at room temperature
Privigen is indicated for the treatment of both primary immunodeficiency and chronic immune thrombocytopenic purpura and will be launched in the first quarter of 2008.
The first proline-stabilized intravenous immunoglobulin (IVIG) that can be stored at room temperature and does not require reconstitution has been approved by the FDA. Privigen (Immune Globulin Intravenous [Human] 10% Liquid), from CSL Behring, is indicated for the treatment of both primary immunodeficiency and chronic immune thrombocytopenic purpura and will be launched in the first quarter of 2008.
To see more Hot off the Press news articles,
To go to the Drug Topics homepage,
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.


























































































































































